These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 10235608

  • 21. Bowman-Birk inhibitor concentrate suppresses experimental autoimmune neuritis via shifting macrophages from M1 to M2 subtype.
    Jin T, Yu H, Wang D, Zhang H, Zhang B, Quezada HC, Zhu J, Zhu W.
    Immunol Lett; 2016 Mar; 171():15-25. PubMed ID: 26791957
    [Abstract] [Full Text] [Related]

  • 22. Effects of the Bowman-Birk inhibitor on growth, invasion, and clonogenic survival of human prostate epithelial cells and prostate cancer cells.
    Kennedy AR, Wan XS.
    Prostate; 2002 Feb 01; 50(2):125-33. PubMed ID: 11816021
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Restoration of connexin 43 by Bowman-Birk protease inhibitor in M5076 bearing mice.
    Suzuki K, Yano T, Sadzuka Y, Sugiyama T, Seki T, Asano R.
    Oncol Rep; 2005 Jun 01; 13(6):1247-50. PubMed ID: 15870950
    [Abstract] [Full Text] [Related]

  • 27. Therapeutic effect of a hydroxynaphthoquinone fraction on dextran sulfate sodium-induced ulcerative colitis.
    Zhang ZL, Fan HY, Yang MY, Zhang ZK, Liu K.
    World J Gastroenterol; 2014 Nov 07; 20(41):15310-8. PubMed ID: 25386079
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of the Bowman-Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation and cis-platinum.
    Kennedy CW, Donahue JJ, Wan XS.
    Nutr Cancer; 1996 Nov 07; 26(2):209-17. PubMed ID: 8875558
    [Abstract] [Full Text] [Related]

  • 30. Growth inhibition and cytotoxicity induced by Bowman-Birk inhibitor concentrate in cisplatin-resistant human ovarian cancer cells.
    Wan XS, Hamilton TC, Ware JH, Donahue JJ, Kennedy AR.
    Nutr Cancer; 1998 Nov 07; 31(1):8-17. PubMed ID: 9682243
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.
    Armstrong WB, Kennedy AR, Wan XS, Atiba J, McLaren CE, Meyskens FL.
    Cancer Epidemiol Biomarkers Prev; 2000 Jan 07; 9(1):43-7. PubMed ID: 10667462
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Suppressing effects of dietary supplementation of soybean trypsin inhibitor on spontaneous, experimental and peritoneal disseminated metastasis in mouse model.
    Kobayashi H, Fukuda Y, Yoshida R, Kanada Y, Nishiyama S, Suzuki M, Kanayama N, Terao T.
    Int J Cancer; 2004 Nov 10; 112(3):519-24. PubMed ID: 15382080
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Molecular cloning and analysis of a gene coding for the Bowman-Birk protease inhibitor in soybean.
    Hammond RW, Foard DE, Larkins BA.
    J Biol Chem; 1984 Aug 10; 259(15):9883-90. PubMed ID: 6086657
    [Abstract] [Full Text] [Related]

  • 39. Effect of a trypsin inhibitor from soybeans (Bowman-Birk) on the secretory activity of the human pancreas.
    Liener IE, Goodale RL, Deshmukh A, Satterberg TL, Ward G, DiPietro CM, Bankey PE, Borner JW.
    Gastroenterology; 1988 Feb 10; 94(2):419-27. PubMed ID: 2446949
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.